Plain-English translation of NCT05919485 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study tests a treatment called transcranial direct current stimulation (tDCS) — a gentle, noninvasive way to stimulate specific areas of the brain using small electrical currents. Researchers want to see if this treatment can help improve thinking, memory, and cognitive skills in people who have been diagnosed with mild cognitive impairment, either related to Parkinson's disease or Alzheimer's disease. The study will compare real stimulation to a sham (fake) treatment and measure changes over 14 days and 3 months.
Many people with Parkinson's disease or early memory loss experience decline in thinking and memory skills, and current treatments have limited ability to reverse these changes. This trial explores whether tDCS — which is portable, affordable, and easy to use — might offer a new way to help preserve or restore cognitive function in these patients.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital for 10 brain stimulation sessions over 14 days — usually about 5 sessions per week, with each session lasting 20 minutes. During each session, small electrodes are placed on your scalp to deliver a gentle electrical current to specific brain areas; you'll feel only mild tingling. You'll also complete thinking and memory tests at the start, after 2 weeks, and again 3 months later, and may have brain imaging scans (MRI and EEG) to measure changes in brain activity.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Turkey (Türkiye)